Lars Damstrup
Chief Tech/Sci/R&D Officer at SCANDION ONCOLOGY A/S
Profile
Lars Damstrup is currently the Chief Medical Officer at Scandion Oncology A.
Previously, he worked as a Senior Medical Director at Symphogen A and Merck Serono GmbH.
Dr. Damstrup holds a doctorate degree from the University of Copenhagen.
Lars Damstrup active positions
Companies | Position | Start |
---|---|---|
SCANDION ONCOLOGY A/S | Chief Tech/Sci/R&D Officer | 2022-12-31 |
Former positions of Lars Damstrup
Companies | Position | End |
---|---|---|
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Chief Tech/Sci/R&D Officer | - |
Merck Serono GmbH
Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Serono GmbH is a German pharmaceutical company that manufactures and distributes pharmaceutical products. The company is based in Darmstadt, Germany. The CEOs of the company are Matthias Pfannkuche, Angelika Heinl, Sören Hermansson. | Chief Tech/Sci/R&D Officer | - |
Training of Lars Damstrup
University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SCANDION ONCOLOGY A/S | Health Technology |
Private companies | 2 |
---|---|
Merck Serono GmbH
Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Serono GmbH is a German pharmaceutical company that manufactures and distributes pharmaceutical products. The company is based in Darmstadt, Germany. The CEOs of the company are Matthias Pfannkuche, Angelika Heinl, Sören Hermansson. | Health Technology |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
- Stock Market
- Insiders
- Lars Damstrup